PROS1 and Rare hereditary thrombophilia: Regarding recurrence-mediated pathways, beyond amplified thrombin generation or impaired fibrinolysis, patients with major congenital thrombophilia (protein C, protein S, or antithrombin deficiencies) experience higher rates of recurrent VTE, including clinically silent events.